Testosterone – various formulations except patches – Androgen deficiency / treatment of transgender patients requiring virilising endocrine therapy

Drug Name (Brand)	Testosterone – various formulations except patches *(Various)*
Indication	Androgen deficiency / treatment of transgender patients requiring virilising endocrine therapy
Traffic Light Classification	Advice
NICE TA (plus link)
Further Information: NICE recommendations, summary of meeting discussions, links to additional supporting docs etc. Cost effectiveness to be taken into consideration. November 2015: As recommended by the NHS Norfolk & Waveney CCGs’ D&TCG testosterone transdermal patches to be added on the TAG recommendations list as Double Red (Not recommended for routine use) in line with the Norfolk & Waveney DROP List. Regarding testosterone transdermal patches, these are currently only available as an expensive unlicensed special. Other more cost-effective options are available. September 2016: The TAG acknowledged publication of NHS England Specialised Services Circular SSC 1620 (22 April 2016) Primary Care Responsibilities in Prescribing and Monitoring Hormone Therapy for Transgender and Non-Binary Adults, regarding the need for testosterone preparations (excluding transdermal patches) to be able to be prescribed by GPs for transgender and non-binary adults on the recommendation of a Gender Identity Clinic specialist.
Date of TAG recommendation / ratification		9/1/2016	Review Date